To forward to colleagues or add to your newsfeed use this link: {View as Webpage} If you're reading but haven't subscribed, click the banner above to receive future issues. | |
Impact of State Targeted Response and State Opioid Response Grants Described in New Briefs | |
To understand how grant recipients have used federal funds to address the opioid crisis, the National Association of State Alcohol and Drug Agency Directors (NASADAD), in partnership with ORN, developed state and territorial-specific briefs that describe highlights of each state alcohol and drug agency’s use of funding from the Substance Abuse and Mental Health Services Administration across the continuum of care. Thematic briefs were also developed to analyze common strategies and services states have implemented for opioid and stimulant misuse and use disorders. Explore the interactive map by clicking on individual states or territories. Access here.
| |
The Role of Housing in Improving Health Outcomes and HIV Care Continuity for People Who Use Drugs: Narratives and Recommendations from Lived Experience
This new resource presents first-hand narratives, research and recommendations to understand and explore housing provision as a comprehensive health and overdose prevention strategy. Developed by ORN partner, the National Alliance of State & Territorial AIDS Directors (NASTAD), it can be used as a series of topic-specific guidance documents or as an overview of person-centered approaches to housing, drug user health, and HIV care. Access here.
| |
New ORN Course on LGBTQ+ Affirming Treatment of Substance Use Disorders
This training is intended to educate service providers on how to deliver affirming treatment and care for LGBTQ+ people who use substances and is meant for practitioners and employees across the spectrum of substance use-related care (e.g., medical providers, behavioral health providers, administrators). The training, from ORN partner Columbia University Department of Psychiatry, consists of a facilitated animation, including data on inequities in substance use among LGBTQ+ communities, the context in which these inequities exist (e.g., minority stress framework), and six case studies of LGBTQ+ people struggling with substance use. The case studies are accompanied by a series of practical, discussion, and self-reflection questions and a guide for the facilitator of the training. Access here.
| |
Upcoming Education and Training Opportunities
| |
Trainings below are sponsored by ORN. A calendar of free trainings from ORN Partner Organizations can be found here. Follow us on LinkedIn for news in your feed. | |
Clinical Essentials on Increasing Motivation and Decreasing Stigma Among Youth with Substance Use Disorders
This prerecorded training series, from ORN partner organization the American Academy of Child and Adolescent Psychiatry (AACAP), was created by a team of child and adolescent psychiatrists with educational and content expertise. It is designed for busy physicians looking to update and expand their knowledge on the most clinically relevant information on children and adolescent with substance use disorders. Learn more.
| |
Stimulants 101
Thursday December 19, 2024 10:00 - 11:00 AM ET
This training, from ORN partner organization the Grayken Center for Addiction TTA at the Boston Medical Center, is intended to provide foundational knowledge of stimulant use disorders as well as an overview of evidence-based interventions. Learn more.
| |
The Fundamentals of Wound Care
Friday December 20, 2024 12:00 - 1:00 PM ET
This training is designed to equip addiction medical treatment teams with the basics of wound assessment and treatment. Offered by ORN partner organization the Grayken Center for Addiction TTA at the Boston Medical Center, topics include assessment of wound tissue type, drainage, cleansing, dressing supplies, special considerations for loop drains, and xylazine-related wounds. Learn more.
| |
Zeroing in on Xylazine
Monday January 6, 2025 11:00 AM - 12:00 PM ET
This training provides knowledge on xylazine, a CNS depressant, linked to an increasing number of overdose deaths in the US. Offered by ORN partner organization the Grayken Center for Addiction TTA at the Boston Medical Center, is will describe the physiologic effects of xylazine, manifestations of xylazine intoxication, overdose, communicable infections associated with xylazine use, and wound care for persons injecting xylazine. Learn more.
| |
Trainings listed below offered by, in collaboration with and/or promoted by SAMHSA. Click here to sign up for SAMHSA newsletters, blogs and email updates. |
Family Treatment Courts: An Evidence-Based Approach to Family-Centered Care
Tuesday December 17, 2024 1:00 - 3:00 PM ET
Learn more about Family Treatment Courts (FTCs) and discover how a family-centered approach helps achieve better outcomes. Presenters and panelists will explore how FTCs implement a collaborative approach to resolve barriers in service access and engagement. Join this event to discover the benefits of a family-centered approach and learn how to help families get the services they need. Offered by the National Center on Substance Abuse and Child Welfare in partnership with SAMHSA. Learn more.
| |
The CARE of Substance Use and Mental Health Disorders in Primary and Integrated Care Services for Hispanic Communities
Tuesday December 17, 2024 1:00 - 2:00 PM ET
The purpose of this webinar is to explore the intersection of mental health, substance use, and integrated healthcare within Hispanic communities. Participants will gain insights into current mental health and substance use trends affecting this population, providing a foundation for understanding their unique needs. Offered by SAMHSA's Hispanic/Latino Behavioral Health Center of Excellence. Learn more.
| |
orn@aaap.org
OpioidResponseNetwork.org
| |
Funding for this initiative was made possible (in part) by grant no. 1H79TI088037 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. | | | | |